F. DuBois Bowman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
F. DuBois Bowman has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Daniel F. Drake
Department of Biostatistics School of Public Health, University of Michigan Ann Arbor Michigan USA
2 shared publications - Daniel E. Huddleston
Department of Neurology, Emory University, Atlanta, USA
1 shared publication For The Alzheimer'S Disease Neuroimaging Initiative
1 shared publication- Gordana Derado
Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention , Atlanta, GA
1 shared publication - James K. Rilling
Department of Psychology Emory University Atlanta Georgia USA
1 shared publication - Lijun Zhang
Department of Population & Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
1 shared publication
Latest Publications
- Open Access
- 3 April 2023
- Published by Wiley in WIREs Computational Statistics
- Vol. 15 (5)
Neuroimaging statistical approaches for determining neural correlates of Alzheimer's disease via positron emission tomography imaging
Alzheimer's disease (AD) is a degenerative disorder involving significant memory loss and other cognitive deficits, manifesting as a progression from normal cognitive functioning to mild cognitive impairment to AD. The sooner an accurate diagnosis of probable AD is made, the easier it is to manage symptoms and plan for future therapy. Functional neuroimaging stands to be a useful tool in achieving early diagnosis. Among the many neuroimaging modalities, positron emission tomography (PET) provides direct regional assessment of, among others, brain metabolism, cerebral blood flow, amyloid deposition—all quantities of interest in the characterization of AD. However, there are analytic challenges in identifying early indicators of AD from these high‐dimensional imaging data sets, and it is unclear whether early indicators of AD are more likely to emerge in localized patterns of brain activity or in patterns of correlation between distinct brain regions. Early PET‐based analyses of AD focused on alterations in metabolic activity at the voxel‐level or in anatomically defined regions of interest. Other approaches, including seed‐voxel and multivariate techniques, seek to characterize metabolic connectivity by identifying other regions in the brain with similar patterns of activity across subjects. We briefly review various neuroimaging statistical approaches applied to determine changes in metabolic activity or metabolic connectivity associated with AD. We then present an approach that provides a unified statistical framework for addressing both metabolic activity and connectivity. Specifically, we apply a Bayesian spatial hierarchical framework to longitudinal metabolic PET scans from the Alzheimer's Disease Neuroimaging Initiative.This article is categorized under: Statistical and Graphical Methods of Data Analysis > Analysis of High Dimensional Data Statistical Learning and Exploratory Methods of the Data Sciences > Modeling Methods Statistical Models > Bayesian Models
- 3 April 2023
- Published by Wiley in WIREs Computational Statistics
- Vol. 15 (5)
Open AccessNeuroimaging statistical approaches for determining neural correlates of Alzheimer's disease via positron emission tomography imaging
Alzheimer's disease (AD) is a degenerative disorder involving significant memory loss and other cognitive deficits, manifesting as a progression from normal cognitive functioning to mild cognitive impairment to AD. The sooner an accurate diagnosis of probable AD is made, the easier it is to manage symptoms and plan for future therapy. Functional neuroimaging stands to be a useful tool in achieving early diagnosis. Among the many neuroimaging modalities, positron emission tomography (PET) provides direct regional assessment of, among others, brain metabolism, cerebral blood flow, amyloid deposition—all quantities of interest in the characterization of AD. However, there are analytic challenges in identifying early indicators of AD from these high‐dimensional imaging data sets, and it is unclear whether early indicators of AD are more likely to emerge in localized patterns of brain activity or in patterns of correlation between distinct brain regions. Early PET‐based analyses of AD focused on alterations in metabolic activity at the voxel‐level or in anatomically defined regions of interest. Other approaches, including seed‐voxel and multivariate techniques, seek to characterize metabolic connectivity by identifying other regions in the brain with similar patterns of activity across subjects. We briefly review various neuroimaging statistical approaches applied to determine changes in metabolic activity or metabolic connectivity associated with AD. We then present an approach that provides a unified statistical framework for addressing both metabolic activity and connectivity. Specifically, we apply a Bayesian spatial hierarchical framework to longitudinal metabolic PET scans from the Alzheimer's Disease Neuroimaging Initiative.This article is categorized under: Statistical and Graphical Methods of Data Analysis > Analysis of High Dimensional Data Statistical Learning and Exploratory Methods of the Data Sciences > Modeling Methods Statistical Models > Bayesian Models
- Open Access
- 18 April 2016
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 10, 131
Multimodal Imaging Signatures of Parkinson's Disease
Parkinson's disease (PD) is a complex neurodegenerative disorder that manifests through hallmark motor symptoms, often accompanied by a range of non-motor symptoms. There is a putative delay between the onset of the neurodegenerative process, marked by the death of dopamine-producing cells, and the onset of motor symptoms, creating an urgent need to develop biomarkers that may yield early PD detection. Neuroimaging offers a non-invasive approach to examining the potential utility of a vast number of functional and structural brain characteristics as biomarkers. We present a statistical framework for analyzing neuroimaging data from multiple modalities to determine features that reliably distinguish PD patients from healthy control (HC) subjects. Our approach builds on elastic net, performing regularization and variable selection, while introducing additional criteria centering on parsimony and reproducibility. We apply our method to data from 42 subjects (28 PD patients and 14 HC). Our approach demonstrates extremely high accuracy, assessed via cross-validation, and isolates brain regions that are implicated in the neurodegenerative PD process.
- 18 April 2016
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 10, 131
Open AccessMultimodal Imaging Signatures of Parkinson's Disease
Parkinson's disease (PD) is a complex neurodegenerative disorder that manifests through hallmark motor symptoms, often accompanied by a range of non-motor symptoms. There is a putative delay between the onset of the neurodegenerative process, marked by the death of dopamine-producing cells, and the onset of motor symptoms, creating an urgent need to develop biomarkers that may yield early PD detection. Neuroimaging offers a non-invasive approach to examining the potential utility of a vast number of functional and structural brain characteristics as biomarkers. We present a statistical framework for analyzing neuroimaging data from multiple modalities to determine features that reliably distinguish PD patients from healthy control (HC) subjects. Our approach builds on elastic net, performing regularization and variable selection, while introducing additional criteria centering on parsimony and reproducibility. We apply our method to data from 42 subjects (28 PD patients and 14 HC). Our approach demonstrates extremely high accuracy, assessed via cross-validation, and isolates brain regions that are implicated in the neurodegenerative PD process.
- Open Access
- 27 March 2006
- Published by Wiley in Human Brain Mapping
- Vol. 27 (5) , 462-470
Determining hierarchical functional networks from auditory stimuli fMRI
We determined connectivity of the human brain using functional magnetic resonance imaging (fMRI) while subjects experienced auditory stimuli in a 2-by-2 factorial design. The two factors in this study were "speaker" (same or different speaker) and "sentence" (same or different sentences). Connectivity studies allow us to ask how spatially remote brain regions are neurophysiologically related given these stimuli. In the context of this study, we examined how the "speaker" effect and "sentence" effect influenced these relationships. We applied a Bayesian connectivity method that determines hierarchical functional networks of functionally connected brain regions. Hierarchy in these functional networks is determined by conditional probabilities of elevated activity. For example, a brain region that becomes active a superset of the time of another region is considered ascendant to that brain region in the hierarchical network. For each factor level, we found a baseline functional network connecting the primary auditory cortex (Brodmann's Area [BA] 41) with the BA 42 and BA 22 of the superior temporal gyrus (STG). We also found a baseline functional network that includes Wernicke's Area (BA 22 posterior), STG, and BA 44 for each factor level. However, we additionally observed a strong ascendant connection from BA 41 to the posterior cingulate (BA 30) and Broca's Area and a stronger connection from Wernicke's Area to STG and the posterior cingulate while passively listening to different sentences rather than the same sentence repeatedly. Finally, our results revealed no significant "speaker" effect or interaction between "speaker" and "sentence."
- 27 March 2006
- Published by Wiley in Human Brain Mapping
- Vol. 27 (5) , 462-470
Open AccessDetermining hierarchical functional networks from auditory stimuli fMRI
We determined connectivity of the human brain using functional magnetic resonance imaging (fMRI) while subjects experienced auditory stimuli in a 2-by-2 factorial design. The two factors in this study were "speaker" (same or different speaker) and "sentence" (same or different sentences). Connectivity studies allow us to ask how spatially remote brain regions are neurophysiologically related given these stimuli. In the context of this study, we examined how the "speaker" effect and "sentence" effect influenced these relationships. We applied a Bayesian connectivity method that determines hierarchical functional networks of functionally connected brain regions. Hierarchy in these functional networks is determined by conditional probabilities of elevated activity. For example, a brain region that becomes active a superset of the time of another region is considered ascendant to that brain region in the hierarchical network. For each factor level, we found a baseline functional network connecting the primary auditory cortex (Brodmann's Area [BA] 41) with the BA 42 and BA 22 of the superior temporal gyrus (STG). We also found a baseline functional network that includes Wernicke's Area (BA 22 posterior), STG, and BA 44 for each factor level. However, we additionally observed a strong ascendant connection from BA 41 to the posterior cingulate (BA 30) and Broca's Area and a stronger connection from Wernicke's Area to STG and the posterior cingulate while passively listening to different sentences rather than the same sentence repeatedly. Finally, our results revealed no significant "speaker" effect or interaction between "speaker" and "sentence."